146 related articles for article (PubMed ID: 9306579)
1. Immunohistochemical expression of bcl-2 protein in squamous cell carcinoma and basaloid carcinoma of the esophagus.
Koide N; Koike S; Adachi W; Amano J; Usuda N; Nagata T
Surg Today; 1997; 27(8):685-91. PubMed ID: 9306579
[TBL] [Abstract][Full Text] [Related]
2. Expression of bcl-2 and p53 oncoproteins in schistosomiasis-associated transitional and squamous cell carcinoma of urinary bladder.
Chaudhary KS; Lu QL; Abel PD; Khandan-Nia N; Shoma AM; el Baz M; Stamp GW; Lalani EN
Br J Urol; 1997 Jan; 79(1):78-84. PubMed ID: 9043502
[TBL] [Abstract][Full Text] [Related]
3. Expression of bcl-2 in oral squamous cell carcinoma: an immunohistochemical study of 90 cases with clinico-pathological correlations.
Lo Muzio L; Mignogna MD; Pannone G; Rubini C; Grassi R; Nocini PF; Ferrari F; Serpico R; Favia G; De Rosa G; Maiorano E
Oncol Rep; 2003; 10(2):285-91. PubMed ID: 12579259
[TBL] [Abstract][Full Text] [Related]
4. Basaloid squamous carcinoma of the oesophagus: a distinct neoplasm with multipotential differentiation.
Cho KJ; Jang JJ; Lee SS; Zo JI
Histopathology; 2000 Apr; 36(4):331-40. PubMed ID: 10759947
[TBL] [Abstract][Full Text] [Related]
5. Expression of Bcl-2 and amplification of c-myc are frequent in basaloid squamous cell carcinomas of the esophagus.
Sarbia M; Loberg C; Wolter M; Arjumand J; Heep H; Reifenberger G; Gabbert HE
Am J Pathol; 1999 Oct; 155(4):1027-32. PubMed ID: 10514383
[TBL] [Abstract][Full Text] [Related]
6. Expression of Bcl-X(L), an antiapoptotic member of the Bcl-2 family, in esophageal squamous cell carcinoma.
Torzewski M; Sarbia M; Heep H; Dutkowski P; Willers R; Gabbert HE
Clin Cancer Res; 1998 Mar; 4(3):577-83. PubMed ID: 9533524
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical and oncogenetic analyses of the esophageal basaloid squamous cell carcinoma in comparison with conventional squamous cell carcinomas.
Imamhasan A; Mitomi H; Saito T; Hayashi T; Takahashi M; Kajiyama Y; Yao T
Hum Pathol; 2012 Nov; 43(11):2012-23. PubMed ID: 22607702
[TBL] [Abstract][Full Text] [Related]
8. Basaloid squamous cell carcinoma of the esophagus: diagnosis and prognosis.
Sarbia M; Verreet P; Bittinger F; Dutkowski P; Heep H; Willers R; Gabbert HE
Cancer; 1997 May; 79(10):1871-8. PubMed ID: 9149011
[TBL] [Abstract][Full Text] [Related]
9. Expression of bcl-2 protein in esophageal squamous cell carcinomas and its association with lymph node metastasis.
Ohbu M; Saegusa M; Kobayashi N; Tsukamoto H; Mieno H; Kakita A; Okayasu I
Cancer; 1997 Apr; 79(7):1287-93. PubMed ID: 9083148
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the predictive value of clinical and histopathological factors as well as the immunoexpression of p53 and bcl-2 proteins in response to preoperative chemotherapy for esophageal squamous cell carcinoma.
Szumilo J; Chibowski D; D browski A
Dis Esophagus; 2000; 13(3):191-7. PubMed ID: 11206631
[TBL] [Abstract][Full Text] [Related]
11. Expression and significance of tumor drug resistance related proteins and beta-catenin in esophageal squamous cell carcinoma.
Gan SY; Zhong XY; Xie SM; Li SM; Peng H; Luo F
Chin J Cancer; 2010 Mar; 29(3):300-5. PubMed ID: 20193114
[TBL] [Abstract][Full Text] [Related]
12. Expression of Bax and apoptosis-related proteins in human esophageal squamous cell carcinoma including dysplasia.
Kurabayashi A; Furihata M; Matsumoto M; Ohtsuki Y; Sasaguri S; Ogoshi S
Mod Pathol; 2001 Aug; 14(8):741-7. PubMed ID: 11504832
[TBL] [Abstract][Full Text] [Related]
13. Expression of Bax, a pro-apoptotic member of the Bcl-2 family, in esophageal squamous cell carcinoma.
Sarbia M; Bittinger F; Grabellus F; Verreet P; Dutkowski P; Willers R; Gabbert HE
Int J Cancer; 1997 Nov; 73(4):508-13. PubMed ID: 9389564
[TBL] [Abstract][Full Text] [Related]
14. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
[TBL] [Abstract][Full Text] [Related]
15. Expression and prognostic value of MG7-Ag in patients with surgically resectable esophageal squamous cell carcinoma.
Zhao Y; Jiang Y; Wang R; Zheng X; Wang X; Jin B; Lu Y; Qiao T; Hong L; Fan D
Ann Surg Oncol; 2007 Sep; 14(9):2621-7. PubMed ID: 17570016
[TBL] [Abstract][Full Text] [Related]
16. Differences and relationships of thymidine phosphorylase expression in tumor-associated macrophages and cancer cells in squamous cell carcinoma of the esophagus.
Koide N; Nishio A; Hiraguri M; Kishimoto K; Nakamura T; Adachi W; Amano J
Dis Esophagus; 2002; 15(1):67-73. PubMed ID: 12060046
[TBL] [Abstract][Full Text] [Related]
17. Abnormal cell proliferation in the p75NTR-positive basal cell compartment of the esophageal epithelium during squamous carcinogenesis.
Okumura T; Shimada Y; Sakurai T; Hori R; Nagata T; Sakai Y; Tsukada K
Dis Esophagus; 2015 Oct; 28(7):634-43. PubMed ID: 24888722
[TBL] [Abstract][Full Text] [Related]
18. Significance of immunohistochemical expression of p27 and involucrin as the marker of cellular differentiation of squamous cell carcinoma of the esophagus.
Nozoe T; Oyama T; Takenoyama M; Hanagiri T; Sugio K; Yasumoto K
Oncology; 2006; 71(5-6):402-10. PubMed ID: 17878746
[TBL] [Abstract][Full Text] [Related]
19. Expression of apoptosis-regulating proteins and outcome of esophageal cancer patients treated by combined therapy modalities.
Sarbia M; Stahl M; Fink U; Willers R; Seeber S; Gabbert HE
Clin Cancer Res; 1998 Dec; 4(12):2991-7. PubMed ID: 9865911
[TBL] [Abstract][Full Text] [Related]
20. MN antigen expression in normal, preneoplastic, and neoplastic esophagus: a clinicopathological study of a new cancer-associated biomarker.
Turner JR; Odze RD; Crum CP; Resnick MB
Hum Pathol; 1997 Jun; 28(6):740-4. PubMed ID: 9191010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
